Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

The American Journal of Medicine

Volumn 87, Issue 2, 1989, Pages 144-152

  Landefeld, C Seth ^a   Goldman, Ohio Lee ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Brigham and Women's and Beth Israel Hospitals ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AGED; BLEEDING; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CEREBRAL HEMORRHAGE; COHORT STUDIES; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; HUMAN; MIDDLE AGE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; WARFARIN;

EID: 0024316072     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(89)80689-8     Document Type: Article

References (41)

1. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
2. Hemorrhagic complications of long-term anticoagulant therapy
3. Hemorrhagic complications of drugs
4. A 7-year analysis of hemorrhage in patients on long-term anticoagulant treatment
5. Hemorrhagic complications of anticoagulant therapy
6. Hemorrhage during long-term anticoagulant therapy. Part 1. Intracranial hemorrhage
7. Problems associated with long-term anticoagulant therapy
8. The significance of hemorrhage during the treatment of patients with the coumarin anticoagulants
9. Age-related risks of long-term oral anticoagulant therapy
10. Safer use of anticoagulants in outpatients (abstr)
11. The cause of bleeding during anticoagulant treatment
12. Use of bishydroxycoumarin (dicumarol) in the presence of impaired renal function
13. Major bleeding resulting from a single dose of dicumarol
14. Dangers of prolonged anticoagulant therapy in hepatic disease
15. The increased hypoprothrombinemic effect of a small dose of dicumarol in congestive heart failure
16. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis
17. Controlled study of the effective level of longterm anticoagulation
18. Bleeding in outpatients treated with warfarin: relationship to the prothrombin time and important remediable lesions
19. Nonparametric estimation from incomplete observations
20. Anticoagulant-related intracerebral hemorrhage
21. Clinical prediction rules. Applications and methodological standards
22. The PHGLM procedure
23. ACCP-NHLBI Conference on Antithrombotic Therapy
24. A decision analytic view of anticoagulant prophylaxis for thromboembolism in heart disease
25. Anticoagulant therapy after acute myocardial infarction
26. Anticoagulants in acute myocardial infarction
27. Assessment of short term anticoagulant administration after cardiac infarction
28. An evaluation of anticoagulant therapy in the treatment of cerebrovascular disease: report of the Veterans Administration cooperative study ofatherosclerosis
29. Anticoagulant therapy in cerebral infarction: report on cooperative study
30. Anticoagulant therapy in cerebral thrombosis and cerebral embolism
31. Cerebrovascular disease: trial of long-term anticoagulant therapy
32. Anticoagulant therapy five years experience with the patient with an established cerebrovascular accident
33. Anticoagulant vs. antiplatelet therapy as prophylactic against cerebral infarction in transient ischemic attacks
34. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves
35. Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement
36. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled study in patients with aortic ball valves
37. The effect of long-term treatment with dicumarol in myocardial infarction
38. Therapeutic level in long-term anticoagulant therapy after myocardial infarction its relation to recurrent infarction and sudden death
39. Low-dose heparin therapy in the long-term management of venous thromboembolism
40. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thromboembolism
41. A prospective study of factors affecting anticoagulant control in a hospital outpatient clinic